Literature DB >> 3713601

Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.

F A Macrae, D J St John, A Ambikapathy, K Sharpe, J F Garner.   

Abstract

Non-compliance in screening programmes for colorectal cancer is likely to be the most important factor limiting the impact of screening on mortality. This study aimed to determine risk factors and correlates of compliance that could be readily identified by general practitioners. A total of 581 eligible subjects aged 40 to 75 years completed a questionnaire that covered demographic factors, personal medical history, family history of colorectal cancer and smoking status. Faecal occult blood tests were then offered by the general practitioner and compliance correlated with responses. The over-all compliance was 44% and increased to 51% for those who accepted the self-testing kit at consultation. For men, compliance increased with increasing level of education and was significantly greater for non-smokers than for smokers. For women, compliance increased with increasing age, and was greater for those with either symptoms and/or a family history of colorectal cancer. A doctor group-practice factor appeared to influence acceptance versus refusal of the test kit from the doctor. A triage approach to screening in general practice may improve over-all compliance and the yield of tumours. With this strategy, patients at high risk (for example, those with a family history of colorectal cancer or in older age groups) are identified first. Particular attention should be given during consultation to those at high risk who have poor compliance profiles (for example male smokers with a family history of colorectal cancer). High-risk subjects with high compliance profiles would need less attention and low-risk individuals would need least attention.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713601     DOI: 10.5694/j.1326-5377.1986.tb112341.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  On attitudes about colorectal cancer screening among gastrointestinal specialists and general practitioners in the Netherlands.

Authors:  J S Terhaar Sive Droste; G D N Heine; M E Craanen; H Boot; C J J Mulder
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

2.  Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.

Authors:  Chloé Maréchal; Isabelle Aimone-Gastin; Cédric Baumann; Bastien Dirrenberger; Jean-Louis Guéant; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2017-02-06       Impact factor: 4.623

Review 3.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  A simple strategy to improve patient adherence to outpatient fecal occult blood testing.

Authors:  J D Freedman; C K Mitchell
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

5.  Screening flexible sigmoidoscopy: patient attitudes and compliance.

Authors:  B D McCarthy; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1993-03       Impact factor: 5.128

6.  Patient compliance with screening for fecal occult blood in family practice.

Authors:  P E Hoogewerf; T G Hislop; B J Morrison; S D Burns; R Sizto
Journal:  CMAJ       Date:  1987-08-01       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.